XML 127 R31.htm IDEA: XBRL DOCUMENT
v3.25.4

CAPITAL STOCK 1 (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2025 | Dec. 31, 2024
Equity [Abstract] |  |
SCHEDULE OF COMMON STOCK SHARES ISSUED TO OFFICERS AND DIRECTORS | Included as part of the issuances was the issuance of the following shares of common stock to officers and directors of the Company: SCHEDULE OF COMMON STOCK SHARES ISSUED TO OFFICERS AND DIRECTORS
Recipient |  | Position With Company |  | Shares |
Jacob D. Cohen |  | Chief Executive Officer and Chairman |  |  | 200,000 |
Antonios Isaac |  | Former President and Director |  |  | 60,000 |
Kenny Myers |  | Director |  |  | 25,000 |
Alex Hamilton |  | Director |  |  | 25,000 |
Lorraine D’Alessio |  | Director |  |  | 25,000 |
Included as part of the issuances was the issuance of the following shares of common stock to officers and directors of the Company:
Recipient |  | Position With Company |  | Shares |
Jacob D. Cohen |  | Chief Executive Officer and Chairman |  |  | 500,000 |
Eugene Johnston |  | Chief Financial Officer |  |  | 100,000 |
Kenny Myers |  | Director |  |  | 100,000 |
Alex Hamilton |  | Director |  |  | 100,000 |
Lorraine D’Alessio |  | Director |  |  | 100,000 |
SCHEDULE OF STOCK OPTION ACTIVITY | The following table summarizes common stock option activity: SCHEDULE OF STOCK OPTION ACTIVITY
|  | Options |  |  | Weighted Average Exercise Price |
Outstanding, December 31, 2023 |  |  | 176,666 |  |  | $ | 10.98 |
Granted |  |  | 13,333 |  |  | $ | 5.55 |
Exercised |  |  | - |  |  |  | - |
Expired / Forfeited |  |  | (33,333 | ) |  |  | 16.50 |
Outstanding, December 31, 2024 |  |  | 156,666 |  |  | $ | 9.34 |
Granted |  |  | 2,000,000 |  |  | $ | 2.30 |
Exercised |  |  | - |  |  |  | - |
Expired / Forfeited |  |  | - |  |  |  | - |
Outstanding, September 30, 2025 |  |  | 2,156,666 |  |  | $ | 2.81 |
Exercisable, September 30, 2025 |  |  | 654,444 |  |  | $ | 3.94 |
| The following table summarizes common stock option activity: SCHEDULE OF STOCK OPTION ACTIVITY
|  | Options |  |  | Weighted Average Exercise Price |
Outstanding, December 31, 2022 |  |  | 83,333 |  |  | $ | 16.50 |
Granted |  |  | 93,333 |  |  | $ | 6.05 |
Exercised |  |  | - |  |  |  | - |
Expired |  |  | - |  |  |  | - |
Outstanding, December 31, 2023 |  |  | 176,666 |  |  | $ | 10.98 |
Exercisable, December 31, 2023 |  |  | 120,833 |  |  | $ | 8.43 |
Granted |  |  | 13,333 |  |  | $ | 5.55 |
Exercised |  |  | - |  |  |  | - |
Expired / Forfeited |  |  | (33,333 | ) |  |  | 16.50 |
Outstanding, December 31, 2024 |  |  | 156,666 |  |  | $ | 9.34 |
Exercisable, December 31, 2024 |  |  | 140,833 |  |  | $ | 8.54 |
SCHEDULE OF OPTIONS OUTSTANDING AND EXERCISABLE | The weighted average exercise prices, remaining lives for options granted, and exercisable as of September 30, 2025 were as follows: SCHEDULE OF OPTIONS OUTSTANDING AND EXERCISABLE
|  |  | Outstanding Options |  |  |  |  |  |  |  |  | Exercisable Options |
Options Exercise Price Per Share |  |  | Shares |  |  | Life (Years) |  |  | Weighted Average Exercise Price |  |  | Shares |  |  | Weighted Average Exercise Price |
$ | 16.50 |  |  |  | 60,000 |  |  |  | 2.87 |  |  | $ | 16.50 |  |  |  | 54,167 |  |  | $ | 16.50 |
$ | 4.80 |  |  |  | 83,333 |  |  |  | 3.25 |  |  | $ | 4.80 |  |  |  | 83,333 |  |  | $ | 4.80 |
$ | 5.55 |  |  |  | 13,333 |  |  |  | 1.78 |  |  | $ | 5.55 |  |  |  | 13,333 |  |  | $ | 5.55 |
$ | 2.30 |  |  |  | 2,000,000 |  |  |  | .99 |  |  | $ | 2.30 |  |  |  | 500,000 |  |  | $ | 2.30 |
| The weighted average exercise prices, remaining lives for options granted, and exercisable as of December 31, 2024 were as follows: SCHEDULE OF OPTIONS OUTSTANDING AND EXERCISABLE
|  |  | Outstanding Options |  |  |  |  |  | Exercisable Options |
Options Exercise Price Per Share |  |  | Shares |  |  | Life (Years) |  |  | Weighted Average Exercise Price |  |  | Shares |  |  | Weighted Average Exercise Price |
$ | 16.50 |  |  |  | 60,000 |  |  |  | 3.61 |  |  | $ | 16.50 |  |  |  | 44,167 |  |  | $ | 16.50 |
$ | 4.80 |  |  |  | 83,333 |  |  |  | 3.99 |  |  | $ | 4.80 |  |  |  | 83,333 |  |  | $ | 4.80 |
$ | 5.55 |  |  |  | 13,333 |  |  |  | 2.53 |  |  | $ | 5.55 |  |  |  | 13,333 |  |  | $ | 5.55 |
SCHEDULE OF OPTIONS FAIR VALUE ASSUMPTIONS | SCHEDULE OF OPTIONS FAIR VALUE ASSUMPTIONS
Fair Value of common stock on measurement date |  | $ | 31.85 – 4.31 |
Risk free interest rate |  |  | 4.13% - 4.10 | %
Volatility |  |  | 142.96% - 136.49 | %
Dividend Yield |  |  | 0 | %
Expected Term |  |  | 5.75 - 3.0 |
| (1) | The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.
| (2) | The trading volatility was determined by calculating the volatility of the Company’s peer group.
| (3) | The Company does not expect to pay a dividend in the foreseeable future.
| (4) | The Company, in accordance with staff accounting bulletin (“SAB”)14-D.2, used the simplified method (plain vanilla) to determine the overall expected term.
| SCHEDULE OF OPTIONS FAIR VALUE ASSUMPTIONS
Fair Value of common stock on measurement date |  | $ | 14.90 – 4.33 |
Risk free interest rate |  |  | 4.10% - 3.30 | %
Volatility |  |  | 232.05% - 92.54 | %
Dividend Yield |  |  | 0 | %
Expected Term |  |  | 6.0-3.0 |
| (1) | The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.
| (2) | The trading volatility was determined by calculating the volatility of the Company’s peer group.
| (3) | The Company does not expect to pay a dividend in the foreseeable future.
| (4) | The Company, in accordance with staff accounting bulletin (“SAB”)14-D.2, used the simplified method (plain vanilla) to determine the overall expected term.
SCHEDULE OF COMMON STOCK WARRANT ACTIVITY | The following table summarizes common stock warrants activity: SCHEDULE OF COMMON STOCK WARRANT ACTIVITY
|  | Warrants |  |  | Weighted Average Exercise Price Per Share |
Outstanding, December 31, 2023 |  |  | 89,533 |  |  | $ | 16.95 |
Granted |  |  | 850,800 |  |  | $ | 5.75 |
Exercised |  |  | - |  |  |  | - |
Expired |  |  | - |  |  |  | - |
Cancelled |  |  | - |  |  |  | - |
Outstanding, December 31, 2024 |  |  | 940,333 |  |  | $ | 5.08 |
Granted |  |  | 1,482,709 |  |  | $ | 1.50 |
Exercised |  |  | 1,427,143 |  |  | $ | 1.50 |
Expired |  |  | - |  |  |  | - |
Cancelled |  |  | - |  |  |  | - |
Outstanding, September 30, 2025 |  |  | 997,899 |  |  | $ | 3.05 |
Exercisable, September 30, 2025 |  |  | 997,899 |  |  | $ | 3.05 |
| The following table summarizes common stock warrants activity: SCHEDULE OF COMMON STOCK WARRANT ACTIVITY
|  | Warrants |  |  | Weighted Average Exercise Price Per Share |
Outstanding, December 31, 2022 |  |  | 133,333 |  |  | $ | 15.00 |
Granted |  |  | 24,500 |  |  |  | 22.14 |
Exercised |  |  | (68,300 | ) |  |  | 15.00 |
Expired |  |  | - |  |  |  | - |
Cancelled |  |  | - |  |  |  | - |
Outstanding, December 31, 2023 |  |  | 89,533 |  |  |  | 16.95 |
Exercisable, December 31, 2023 |  |  | 89,533 |  |  |  | 16.95 |
Granted |  |  | 850,800 |  |  |  | 5.75 |
Exercised |  |  | - |  |  |  | - |
Expired |  |  | - |  |  |  | - |
Cancelled |  |  | - |  |  |  | - |
Outstanding, December 31, 2024 |  |  | 940,333 |  |  |  | 5.08 |
Exercisable, December 31, 2024 |  |  | 940,333 |  |  | $ | 5.08 |
SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE | The weighted average exercise prices, remaining lives for warrants granted, and exercisable as of September 30, 2025, were as follows: SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE
|  |  | Outstanding and Vested Warrants |
Weighted Average Warrant Exercise Price Per Share |  |  | Shares |  |  | Life (Years) |
$ | 3.05 |  |  |  | 997,899 |  |  |  | 3.75 |
| The weighted average exercise prices, remaining lives for warrants granted, and exercisable as of December 31, 2024, were as follows: SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE
|  |  | Outstanding and Vested Warrants |
Weighted Average Warrant Exercise Price Per Share |  |  | Shares |  |  | Life (Years) |
$ | 5.75 |  |  |  | 940,333 |  |  |  | 4.46 |
SCHEDULE OF WARRANTS FAIR VALUE ASSUMPTIONS | SCHEDULE OF WARRANTS FAIR VALUE ASSUMPTIONS
Fair Value of common stock on measurement date |  | $ | 3.12 - $51.12 |
Risk free interest rate |  |  | From 3.82% to 4.59 | %
Volatility |  |  | From 135.75% to 238.00 | %
Dividend Yield |  |  | 0 | %
Expected Term |  |  | 3 - 5 years |
| (1) | The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.
| (2) | The trading volatility was determined by calculating the volatility of the Company’s peer group.
| (3) | The Company does not expect to pay a dividend in the foreseeable future.
| SCHEDULE OF WARRANTS FAIR VALUE ASSUMPTIONS
Fair Value of common stock on measurement date |  | $ | 3.10 - $10.90 |
Risk-free interest rate |  |  | From 2.95% to 4.38 | %
Volatility |  |  | From 81.92% to 239.06 | %
Dividend Yield |  |  | 0 | %
Expected Term |  |  | 3 - 5 years |
| (1) | The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.
| (2) | The trading volatility was determined by calculating the volatility of the Company’s peer group.
| (3) | The Company does not expect to pay a dividend in the foreseeable future.

X
- Definition Schedule Of Common Stock Issued To Officers And Directors [Table Text Block] + References No definition available. + Details
Name: | MGRX_ScheduleOfCommonStockIssuedToOfficersAndDirectorsTableTextBlock
Namespace Prefix: | MGRX_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of Warrants Plans By Exercise Price Range [Table Text Block] + References No definition available. + Details
Name: | MGRX_ScheduleOfWarrantsPlansByExercisePriceRangeTextBlock
Namespace Prefix: | MGRX_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Warrants Valuation Assumptions [Table Text Block] + References No definition available. + Details
Name: | MGRX_ScheduleOfWarrantsValuationAssumptionsTableTextBlock
Namespace Prefix: | MGRX_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration